GlassScriptPhysician profile
Kesha Wilford
NPI 1962677823
$11,146.57
in general payments reported to CMS, 2019-2025
70 companies · $632 in 2025
The $632 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,225 · 2020: $1,411 · 2021: $2,126 · 2022: $1,805 · 2023: $923 · 2024: $1,025 · 2025: $632.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,580.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,580.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $1,409.82 | 2019-2025 | Austedo Xr, Austedo Xr, Austedo |
| Abbvie INC. | $831.73 | 2020-2025 | Botox, Duopa, Vraylar |
| Jazz Pharmaceuticals INC. | $642.77 | 2019-2023 | Xywav |
| Ucb, INC. | $602.87 | 2019-2024 | Zilbrysq, Rystiggo, Briviact |
| Harmony Biosciences LLC | $560.55 | 2020-2025 | Wakix |
| Supernus Pharmaceuticals, INC. | $540.31 | 2019-2021 | |
| Eisai INC. | $456.45 | 2019-2025 | |
| Lilly USA, LLC | $446.28 | 2019-2025 | Amyvid, Emgality, Kisunla |
| Amgen INC. | $411.06 | 2019-2024 | Uplizna |
| Mdd US Operations, LLC | $349.72 | 2024 | Gocovri |
| Novartis Pharmaceuticals Corporation | $342.07 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $294.73 | 2019-2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $274.84 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $264.77 | 2020-2021 | |
| Avanir Pharmaceuticals, INC. | $257.47 | 2019-2022 |
Show all 70 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kesha Wilford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.